UARK 2003-33, Total Therapy III
NCT00081939
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
303
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Velcade
DRUG:
Thalidomide
Sponsor
University of Arkansas